Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02KLD
|
||||
| Former ID |
DIB006976
|
||||
| Drug Name |
BVT-74316
|
||||
| Synonyms |
BVT-5182; BVT-5182C; 5-HT6 antagonists (obesity), Biovitrum; 5-HT6 antagonists (obesity), Proximagen
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Obesity [ICD9: 278; ICD10:E66] | Phase 1 | [548202] | ||
| Company |
Swedish Orphan Biovitrum AB
|
||||
| Formula |
C21H24N2O5S
|
||||
| Canonical SMILES |
c1(ccc(c(c1)NS(=O)(=O)c1cc2c(c(c1)OC1CCNCC1)occ2)OC)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 6 receptor | Target Info | Antagonist | [544074] | |
| PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.